Crossmark

BET bromodomain inhibition potentiates antitumor activity of tumor-associated macrophages and enhances anti-CD47 immunotherapy in triple-negative breast cancer

Crossref DOI link: https://doi.org/10.1007/s10495-025-02229-3

Published Online: 2026-01-10

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mei, Fuxing

Li, Delin

Zhu, Nannan

Zhu, Tao

Xie, Han

Liu, Yue

Chen, Lei

Zhang, Xiao

Ji, Wei
Funding

Funding for this research was provided by:

Science and Technology Project of Jilin Provincial Department of Education (JJKH20230802KJ)

Department of Science and Technology of Jilin Province (20200404198YY)
License Information

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-01
More Information

Article History

Received: 4 August 2025

Accepted: 21 October 2025

First Online: 10 January 2026

Declarations

:

: The authors declare no competing interests.

: All animal operations and care procedures were reviewed and approved by the Ethics Committee of Xuzhou Medical University, approval number 202402T001. All treatments were performed gently, all surgeries were performed under anesthesia, and all efforts were made to minimize animal suffering.

Document is current

Any future updates will be listed below